Members |
acceptabilityId |
3D |
Acceptable (foundation metadata concept) |
3D (three dimensional) external beam teleradiotherapy |
Acceptable (foundation metadata concept) |
3D (three dimensional) obstetric ultrasonography |
Acceptable (foundation metadata concept) |
3D (three dimensional) obstetric ultrasonography in third trimester |
Acceptable (foundation metadata concept) |
3D - Three-dimensional |
Acceptable (foundation metadata concept) |
3D CEUS (three dimensional contrast enhanced ultrasound) of abdominal aortic EVAR (endovascular aneurysm repair) |
Acceptable (foundation metadata concept) |
3D cone beam CT of mandible |
Acceptable (foundation metadata concept) |
3D mode ultrasound |
Preferred (foundation metadata concept) |
3D mode ultrasound (qualifier value) |
Preferred (foundation metadata concept) |
3D treatment planning |
Acceptable (foundation metadata concept) |
3D-EBRT - three dimensional external beam radiation therapy |
Acceptable (foundation metadata concept) |
3DI - Developmental, dimensional and diagnostic interview |
Acceptable (foundation metadata concept) |
3H post 100 g glucose PO |
Acceptable (foundation metadata concept) |
3H post dose glucose |
Acceptable (foundation metadata concept) |
3H post incubation |
Acceptable (foundation metadata concept) |
3M syndrome |
Acceptable (foundation metadata concept) |
3MC syndrome |
Acceptable (foundation metadata concept) |
3MI |
Acceptable (foundation metadata concept) |
3MS (Modified Mini-Mental State) Examination score |
Acceptable (foundation metadata concept) |
3P test |
Acceptable (foundation metadata concept) |
3TC |
Acceptable (foundation metadata concept) |
3a |
Preferred (foundation metadata concept) |
3alpha,7alpha,12alpha-trihydroxycholestan-26-al 26-dehydrogenase |
Preferred (foundation metadata concept) |
3alpha,7alpha,12alpha-trihydroxycholestan-26-al 26-dehydrogenase (substance) |
Preferred (foundation metadata concept) |
3alpha-hydroxy-5beta-androstane-17-one 3alpha-dehydrogenase |
Preferred (foundation metadata concept) |
3alpha-hydroxy-5beta-androstane-17-one 3alpha-dehydrogenase (substance) |
Preferred (foundation metadata concept) |
3alpha-hydroxycholanate dehydrogenase |
Preferred (foundation metadata concept) |
3alpha-hydroxycholanate dehydrogenase (substance) |
Preferred (foundation metadata concept) |
3alpha-hydroxysteroid dehydrogenase |
Preferred (foundation metadata concept) |
3alpha-hydroxysteroid dehydrogenase (substance) |
Preferred (foundation metadata concept) |
3b |
Preferred (foundation metadata concept) |
3beta-hydroxy-4alpha-methylcholestenecarboxylate dehydrogenase (decarboxylating) |
Preferred (foundation metadata concept) |
3beta-hydroxy-4alpha-methylcholestenecarboxylate dehydrogenase (decarboxylating) (substance) |
Preferred (foundation metadata concept) |
3beta-hydroxy-delta 5-steroid dehydrogenase |
Preferred (foundation metadata concept) |
3beta-hydroxy-delta 5-steroid dehydrogenase (substance) |
Preferred (foundation metadata concept) |
3beta-hydroxy-delta^5^-C>2<7-steroid oxido-reductase |
Acceptable (foundation metadata concept) |
3beta-hydroxysteroid dehydrogenase |
Preferred (foundation metadata concept) |
3beta-hydroxysteroid dehydrogenase (substance) |
Preferred (foundation metadata concept) |
3c |
Preferred (foundation metadata concept) |
3di (Developmental Dimensional and Diagnostic Interview) score |
Acceptable (foundation metadata concept) |
3p partial monosomy syndrome |
Preferred (foundation metadata concept) |
3p partial monosomy syndrome (disorder) |
Preferred (foundation metadata concept) |
3p partial trisomy syndrome |
Preferred (foundation metadata concept) |
3p partial trisomy syndrome (disorder) |
Preferred (foundation metadata concept) |
3p syndrome |
Acceptable (foundation metadata concept) |
3p25.3 deletion syndrome |
Preferred (foundation metadata concept) |
3p25.3 deletion syndrome (disorder) |
Preferred (foundation metadata concept) |
3p25.3 microdeletion syndrome |
Acceptable (foundation metadata concept) |
3p25.3 microdeletion syndrome is a rare chromosomal anomaly characterized by intellectual disability, epilepsy or EEG abnormalities, poor speech, ataxia, and stereotypic hand movements. |
Preferred (foundation metadata concept) |
3q partial trisomy syndrome |
Preferred (foundation metadata concept) |
3q partial trisomy syndrome (disorder) |
Preferred (foundation metadata concept) |
3q subtelomere deletion syndrome |
Acceptable (foundation metadata concept) |
3q13 microdeletion syndrome |
Preferred (foundation metadata concept) |
3q13 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
3q23 microdeletion syndrome |
Acceptable (foundation metadata concept) |
3q26 microduplication syndrome |
Preferred (foundation metadata concept) |
3q26 microduplication syndrome (disorder) |
Preferred (foundation metadata concept) |
3q26q27 microdeletion syndrome |
Preferred (foundation metadata concept) |
3q26q27 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
3q27.3 microdeletion syndrome |
Preferred (foundation metadata concept) |
3q27.3 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
3q29 microdeletion syndrome |
Preferred (foundation metadata concept) |
3q29 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
3q29 microduplication |
Preferred (foundation metadata concept) |
3rd |
Acceptable (foundation metadata concept) |
3rd HiB and DTP vaccine given |
Preferred (foundation metadata concept) |
3rd HiB and DTP vaccine given (situation) |
Preferred (foundation metadata concept) |
3rd Hib and DTP vaccine given |
Preferred (foundation metadata concept) |
3rd Japanese encephalitis vaccination |
Preferred (foundation metadata concept) |
3rd Japanese encephalitis vaccination |
Preferred (foundation metadata concept) |
3rd Japanese encephalitis vaccination (procedure) |
Preferred (foundation metadata concept) |
3rd Japanese encephalitis vaccination (procedure) |
Preferred (foundation metadata concept) |
3rd floor |
Acceptable (foundation metadata concept) |
3rd hepatitis A junior vaccination |
Acceptable (foundation metadata concept) |
3rd left lumbar vein |
Acceptable (foundation metadata concept) |
3rd nerve palsy |
Acceptable (foundation metadata concept) |
3rd nerve palsy |
Acceptable (foundation metadata concept) |
3rd right lumbar vein |
Acceptable (foundation metadata concept) |
3rd specimen |
Acceptable (foundation metadata concept) |
3rd trimester |
Acceptable (foundation metadata concept) |
3x /day |
Acceptable (foundation metadata concept) |
4 |
Preferred (foundation metadata concept) |
4 |
Preferred (foundation metadata concept) |
4 |
Acceptable (foundation metadata concept) |
4 (qualifier value) |
Preferred (foundation metadata concept) |
4 Buck shot |
Preferred (foundation metadata concept) |
4 Buck shot, device |
Acceptable (foundation metadata concept) |
4 Buck shot, device (qualifier value) |
Preferred (foundation metadata concept) |
4 French gauge |
Preferred (foundation metadata concept) |
4 French gauge (qualifier value) |
Preferred (foundation metadata concept) |
4 MUGS |
Acceptable (foundation metadata concept) |
4 PD base out prism test |
Acceptable (foundation metadata concept) |
4 WAY FOGGER |
Preferred (foundation metadata concept) |
4 WAY FOGGER (product) |
Preferred (foundation metadata concept) |
4 diopter prism test |
Preferred (foundation metadata concept) |
4 diopter prism test (procedure) |
Preferred (foundation metadata concept) |
4 hours |
Preferred (foundation metadata concept) |
4 hours (qualifier value) |
Preferred (foundation metadata concept) |
4 hours post-dose |
Preferred (foundation metadata concept) |
4 hours post-dose (qualifier value) |
Preferred (foundation metadata concept) |
4 level of presenting part in relation to ischial spines |
Preferred (foundation metadata concept) |